Source - SMW
JP Morgan Cazenove today reaffirms its overweight investment rating on Circassia Pharmaceuticals Plc (LON:CIR) and cut its price target to 140p (from 170p).

Related Charts

Circassia Pharmaceuticals (CIR)

0.00 (0.00%)
delayed 18:15PM